Abstract
Liver cirrhosis is a major risk factor for the development of hepatocellular carcinoma, hence the need to screen those patients by means of liver ultrasound every 6 months. The differential diagnosis between a regenerative nodule, a dysplastic one and hepatocellular carcinoma is made based on a contrast imaging method (CEUS, MRI or CT) as they all have comparative sensitivities.
MeSH terms
-
Carcinoma, Hepatocellular / diagnostic imaging*
-
Carcinoma, Hepatocellular / pathology
-
Contrast Media*
-
Diagnosis, Differential
-
Humans
-
Liver Cirrhosis / diagnostic imaging*
-
Liver Cirrhosis / pathology
-
Liver Neoplasms / diagnostic imaging*
-
Liver Neoplasms / pathology
-
Magnetic Resonance Imaging
-
Risk Factors
-
Sensitivity and Specificity
-
Tomography, X-Ray Computed
-
Ultrasonography